Status:
COMPLETED
COVID-19 Pandemic Induced Stress and Symptoms
Lead Sponsor:
University of California, San Francisco
Conditions:
Stress Reaction
Stress, Emotional
Eligibility:
All Genders
18+ years
Brief Summary
The previous survey of oncology patients at University of California, San Francisco in 2020-2021 found an alarmingly high symptom burden and high levels of stress and loneliness among respondents. Thi...
Detailed Description
OBJECTIVES: 1. Evaluate for associations among general and disease-specific measures of stress and measures of social isolation and loneliness. 2. Evaluate for associations between general and diseas...
Eligibility Criteria
Inclusion
- Current/Previous diagnosis of cancer
- Able to read, write, and understand English
- Able to complete the study questionnaires on line
- Able consent to participate.
Exclusion
- Participants of our previous COVID survey study who opted out of future research.
Key Trial Info
Start Date :
February 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2023
Estimated Enrollment :
415 Patients enrolled
Trial Details
Trial ID
NCT06036251
Start Date
February 1 2023
End Date
April 30 2023
Last Update
September 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94143